12:00 AM
 | 
Aug 07, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

University of Tokyo preclinical data

Tokyo researchers published in Nature the development of a dimeric ribozyme (maxizyme) targeting the junction sequence of the chimeric Bcr-Abl mRNA, which encodes a...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >